5AM Partners IV, LLC - Apr 10, 2023 Form 4 Insider Report for Pear Therapeutics, Inc. (PEARQ)

Role
10%+ Owner
Signature
5AM Partners IV, LLC, By /s/ Scott M. Rocklage, Managing Member
Stock symbol
PEARQ
Transactions as of
Apr 10, 2023
Transactions value $
-$1,985,294
Form type
4
Date filed
4/12/2023, 04:51 PM
Previous filing
Nov 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PEARQ Class A Common Stock Sale -$1.54M -12.8M -100% $0.12* 0 Apr 10, 2023 By 5AM Ventures IV, L.P. F1, F2
transaction PEARQ Class A Common Stock Sale -$64.2K -535K -100% $0.12* 0 Apr 10, 2023 By 5AM Co-Investors IV, L.P. F1, F3
transaction PEARQ Class A Common Stock Sale -$381K -3.17M -94.07% $0.12* 200K Apr 10, 2023 By 5AM Opportunities I, L.P. F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

5AM Partners IV, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.11 to $0.19 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The shares are directly held by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.
F3 The shares are directly held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Dr. Rocklage and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.
F4 Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab is a managing member of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein.